Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2020–2025 · research · R01
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma
Frederick F Lang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
New Therapeutic Approaches for Stratified High-REST GBM Subtype
Sadhan Majumder · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
ERK mediated regulation of RbAp46/48 during female germ cell development
Swathi Arur · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2026 · research · R00
Elucidating the role of support signaling in promoting minimal residual disease in mouse models of oncogene-driven lung cancer
Aria Vaishnavi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2023 · research · R00
QUANTITATIVE IMAGING BIOMARKERS OF TREATMENT RESPONSE AND PROGNOSIS IN BREAST CANCER
Jia Wu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R50
Single Cell Spatial Analysis in Tissue
Jared Kyle Burks · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2024 · grant · Innovator Award: Digital Technologies
Artificial intelligence to automate the use of radiotherapy to treat acute oncological conditions such as severe pain, bleeding and neurological symptoms in patients with advanced cancers
Dr Laurence Court · The University of Texas MD Anderson Cancer Center · funded by Wellcome Trust
2020–2025 · research · R01
Role of UBR7, a novel H2BK120 E3 ubiquitin ligase, in suppression of breast cancer
Kunal Rai · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2024 · research · R34
Pilot Study to Evaluate a Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers
Janice Anita Blalock · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2023 · research · R03
ω-3 fatty acid-derived mediators promote resolution of inflammation: Uncovering new strategies for preventing colitis-associated colon cancer
Xiangsheng Zuo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
ERK mediated regulation of RbAp46/48 during female germ cell development
Swathi Arur · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020 · research · ASH Research Restart Award
ASH Research Restart Award 2020: Prerna Malaney
Prerna Malaney · The University of Texas MD Anderson Cancer Center · funded by American Society of Hematology
2020 · career development · Young Investigator Award
Anti-PR1 Immune Therapy for Myeloid Leukemia
Abhishek Maiti · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2020 · career development · Career Development Award
Targeting the Replication Stress Response to Induce Anti-Cancer Immunity in Advanced Solid Malignancies
Patrick Pilie · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2020 · research · AACR Gertrude B. Elion Cancer Research Award
Interplay between ethnicity & biology in response to checkpoint inhibition
Kaysia Ludford · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2020 · career development · Young Investigator Award
Validation of biomarkers of autophagic flux in patients with RAS mutant tumors in response to MAPKi in colorectal cancer
Jason Henry · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2020 · research · ASH Research Restart Award
ASH Research Restart Award 2020: Natthakan Thongon
Natthakan Thongon · The University of Texas MD Anderson Cancer Center · funded by American Society of Hematology
2020 · career development · Young Investigator Award
Characterizing and targeting the tumor immune microenvironment in FGFR3-mutated bladder cancer.
Alexander Andreev-Drakhlin · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2020 · career development · Career Development Award
Understanding the impact of anti-VEGF therapy on resistance mechanisms and immune modulation in EGFR-mutant NSCLC
Xiuning Le · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2020 · research · AACR-The Mark Foundation for Cancer Research "Science of the Patient" (SOP) Grants
Liver PAH defect provokes immune resistance
Liuqing Yang · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2020 · career development · Young Investigator Award
Modulating immunometabolism to improve the activity of CAR-NK cells targeting CD70 in Renal Cell Carcinoma
Hind Rafei · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2020–2026 · research · R01
Regulation of tumor recurrence by stress activated neutrophils
Rugang Zhang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2026 · cooperative agreement · U01
Predict radiation-induced shifts in patient-specific tumor immune ecosystem composition to harness immunological consequences of radiotherapy
Heiko Enderling · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2026 · research · R01
Improving Health Utilization and Quality of Life in Head and Neck Cancer Patients Undergoing Chemoradiation and their Family Caregivers
Kathrin Milbury · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2027 · research · R00
Elucidating the role of support signaling in promoting minimal residual disease in mouse models of oncogene-driven lung cancer
Aria Vaishnavi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · program · P01
Core B: Bioinformatics & Biostatistics Core
S. Stephen Yi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · program · P01
Core A: Administrative Core
Ellen R Richie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · program · P01
Core C: Human Thymus Core
Laura P. Hale · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · program · P01
Project 1 - Molecular mechanisms controlling TEC dynamics and lineage hierarchies in the perinatal thymus
Ellen R Richie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · program · P01
Project-004
Ellen R Richie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · program · P01
Core B: Bioinformatics & Biostatistics Core
S. Stephen Yi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · program · P01
Core A: Administrative Core
Ellen R Richie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · program · P01
Project 1 - Molecular mechanisms controlling TEC dynamics and lineage hierarchies in the perinatal thymus
Ellen R Richie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2023 · research · R01
Synthetic Lethal Targeting of CREBBP/EP300 in Head and Neck Squamous Cell Carcinoma
Curtis Pickering · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Building a Diverse Biomedical Workforce Through Communication Across Difference
Carrie A. Cameron · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Building a Diverse Biomedical Workforce Through Communication Across Difference
Carrie A. Cameron · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2026 · career development · K08
Developing a Decision Tool for Chemotherapy in Older Women with Early Stage Breast Cancer
Meghan Sri Karuturi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
DELINEATING THE EVOLUTION AND ECOLOGY OF CHEMORESISTANCE IN BREAST CANCER WITH SINGLE CELL GENOMICS
Nicholas Navin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
Michael Davies · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
